What is Ledipasvir-sofosbuvir?

Category: Prescription Drugs

Most popular types: Harvoni Hepcvir-L

false

Ledipasvir-sofosbuvir is a combination of two antiviral medications used to treat chronic hepatitis C (CHC) genotype 1 infection in adults.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
1
Moderate
2
Mild
4
None
5

Commonly reported side effects and conditions associated with Ledipasvir-sofosbuvir

Side effect Patients
Headaches 4
Insomnia 2
Constipation 1
Fatigue 1
Heartache 1
Joint stiffness 1

Show all 12 reported side effects

Dosages

Based on patients currently taking Ledipasvir-sofosbuvir

Dosage Patients
28 mg daily 1
90-400 mg daily 1

Why patients stopped taking Ledipasvir-sofosbuvir

Multiple reasons could be selected

Reason Patients
Course of treatment ended 9
See all 9 patients who've stopped taking Ledipasvir-sofosbuvir

Duration

Currently taking Ledipasvir-sofosbuvir

Duration Patients
1 - 6 months 1
2 - 5 years 2

Stopped taking Ledipasvir-sofosbuvir

Duration Patients
1 - 6 months 8
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 11
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 2
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 8
Cost per month
Cost per month Evaluations
$200+ 2
$100-199 0
$50-99 0
$25-49 0
< $25 9
Not specified 1

What people switch to and from

Patients started taking Ledipasvir-sofosbuvir after stopping:

Treatment Patients
Ribavirin (Copegus) 2
Peginterferon alfa-2b (PegIntron Redipen) 1
Ritonavir-dasabuvir-ombitasvir-paritaprevir 1
Telaprevir 1
Last updated:
There are no evaluations for Ledipasvir-sofosbuvir.